UBS AM
SRDX

UBS AM’s Surmodics SRDX Stock Holding History

UBS AM’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,113
Closed -$481K – 2677
2023
Q2 		$481K Hold
21,113
– – ﹤0.01% 2337
2023
Q1 		$481K Buy
21,113
+2,672
+14% +$68.8K ﹤0.01% 2337
2022
Q4 		$629K Buy
18,441
+449
+2% +$15K ﹤0.01% 2081
2022
Q3 		$547K Hold
17,992
– – ﹤0.01% 2308
2022
Q2 		$670K Hold
17,992
– – ﹤0.01% 2166
2022
Q1 		$816K Buy
17,992
+174
+1% +$7.62K ﹤0.01% 2249
2021
Q4 		$858K Buy
17,818
+244
+1% +$12.3K ﹤0.01% 2293
2021
Q3 		$977K Buy
17,574
+2,598
+17% +$144K ﹤0.01% 2179
2021
Q2 		$812K Buy
14,976
+493
+3% +$27.1K ﹤0.01% 2325
2021
Q1 		$812K Buy
14,483
+4,553
+46% +$227K ﹤0.01% 2185
2020
Q4 		$432K Hold
9,930
– – ﹤0.01% 2338
2020
Q3 		$386K Buy
+9,930
New +$436K ﹤0.01% 2240
2020
Q2 		– Sell
-7,042
Closed -$235K – 2523
2020
Q1 		$235K Sell
7,042
-290
-4% -$10.5K ﹤0.01% 2226
2019
Q4 		$304K Buy
7,332
+55
+0.8% +$2.32K ﹤0.01% 2364
2019
Q3 		$333K Buy
7,277
+1,646
+29% +$71.7K ﹤0.01% 2419
2019
Q2 		$243K Buy
+5,631
New +$238K ﹤0.01% 2481
2018
Q4 		– Sell
-7,688
Closed -$574K – 2823
2018
Q3 		$574K Buy
7,688
+3,499
+84% +$241K ﹤0.01% 2030
2018
Q2 		$231K Buy
+4,189
New +$193K ﹤0.01% 2415
2016
Q4 		– Sell
-10,499
Closed -$316K – 2643
2016
Q3 		$316K Hold
10,499
– – ﹤0.01% 2239
2016
Q2 		$247K Hold
10,499
– – ﹤0.01% 2318
2016
Q1 		$193K Hold
10,499
– – ﹤0.01% 2443
2015
Q4 		$213K Hold
10,499
– – ﹤0.01% 2502
2015
Q3 		$229K Hold
10,499
– – ﹤0.01% 2424
2015
Q2 		$246K Buy
+10,499
New +$263K ﹤0.01% 2487

Other funds holding SRDX

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

UBS AM's SRDX Position: Q3 2023 in Review

UBS AM sold out of Surmodics (SRDX) in Q3 2023, closing a stake of 21,113 shares — an estimated $481K sold.

UBS AM first reported a position in SRDX in Q2 2015 and held it in 24 quarters. The position peaked at $977K in Q3 2021. 103 funds tracked by Wall St. Rank hold SRDX as of Q3 2023.

  • UBS AM reported no remaining Surmodics position as of Q3 2023 after selling out during the quarter.
  • UBS AM sold 21,113 Surmodics shares in Q3 2023, an estimated $481K.
  • UBS AM first reported a position in Surmodics in Q2 2015 and held it in 24 quarters.
  • UBS AM's Surmodics position peaked at $977K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Surmodics as of Q3 2023.

Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.